Sam Chun Dang Pharm Overview

  • Founded
  • 1943
Founded
  • Status
  • Public
  • Employees
  • 405
Employees
  • Stock Symbol
  • 000250
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $63.69
  • (As of Thursday Closing)

Sam Chun Dang Pharm General Information

Description

Samchundang Pharm Co Ltd is engaged in manufacturing, distributing, importing, and exporting pharmaceuticals in South Korea. The company offers ophthalmology, cardiovascular, endocrinology, antibacterial, anti-fungal, antiviral, respiratory, anti-inflammatory, antihistamine, and musculoskeletal products, as well as gastro intestines and vitamins.

Contact Information

Website
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Other Pharmaceuticals and Biotechnology
Stock Exchange
KRX
Primary Office
  • 1606-1 Seocho-dong, Seocho-gu
  • Seoul, 137-877
  • South Korea
+82 00-0000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Sam Chun Dang Pharm Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$63.69 $64.63 $16.98 - $86.70 $1.41B 22.1M 955K -$0.34

Sam Chun Dang Pharm Financials Summary

In Thousands,
USD
TTM 30-Sep-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 1,025,999 647,002 723,173 303,777
Revenue 143,948 160,026 145,536 141,615
EBITDA 4,729 21,090 17,602 25,672
Net Income (7,270) 8,963 7,965 11,036
Total Assets 263,534 250,486 233,530 215,368
Total Debt 21,826 20,592 18,023 4,994
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Sam Chun Dang Pharm Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sam Chun Dang Pharm‘s full profile, request access.

Request a free trial

Sam Chun Dang Pharm Executive Team (3)

Name Title Board Seat Contact Info
Jeon-Kyo Park President & Chief Executive Officer
Jeon In-Seok Senior Managing Director
Kim Dae-Wook Senior Managing Director
To view Sam Chun Dang Pharm’s complete executive team members history, request access »

Sam Chun Dang Pharm Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sam Chun Dang Pharm Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000 00000 27-Dec-2012 000000000000000000 0000 Diagnostic Equipment
To view Sam Chun Dang Pharm’s complete acquisitions history, request access »

Sam Chun Dang Pharm Subsidiaries (1)

Company Name Industry Location Founded
000 00000 Diagnostic Equipment Seoul, South Korea 0000
To view Sam Chun Dang Pharm’s complete subsidiaries history, request access »